Testing the Effect of Press Guides on Health Journalists
NCT ID: NCT00938938
Last Updated: 2010-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2009-06-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by English-speaking Patients
NCT03095586
The Effect of Newspaper Reporting on COVID-19 Vaccine Hesitancy: a Randomised Controlled Trial
NCT05582564
Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin by English-speaking Patients
NCT03094078
Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by French-speaking Patients
NCT03095924
Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin by English-speaking Population
NCT03094104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Journalists traditionally write newspaper articles about medical research using information from press releases and the medical journal article's abstract or full text. The objective is to test whether the addition of a 'press guide' (a one-page summary of the study findings) in addition to these other materials improves comprehension of facts about the study article and the overall judgment of the newsworthiness of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Press guide plus press release
Participants in the intervention group will receive a press guide (a one-page summary of study findings written by the investigators) in addition to the journal's full narrative press release for the selected article, a copy of the article's abstract, and a link to the full text of the journal article.
Press Guide
The press guide is a 1-page summary of the study findings, written by the investigators.
Press release only
Participants in the control group will receive the journal's full narrative press release for the selected article, a copy of the article's abstract, and a link to the full text of the journal article.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Press Guide
The press guide is a 1-page summary of the study findings, written by the investigators.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The symposium, which is held annually, is open to journalists across the country and from abroad.
Participants who are Health Journalists at the Health Journalism 2010 conference will be invited to participate in the study. This annual conference is being held in Chicago, IL at the Hyatt Regency McCormick Place During April 22, 2010-April 25, 2010.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
White River Junction Veterans Affairs Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
White River Junction VAMC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa M. Schwartz, MD, MS
Role: PRINCIPAL_INVESTIGATOR
White River Junction Veterans Affairs Medical Center
References
Explore related publications, articles, or registry entries linked to this study.
Woloshin S, Schwartz LM, Casella SL, Kennedy AT, Larson RJ. Press releases by academic medical centers: not so academic? Ann Intern Med. 2009 May 5;150(9):613-8. doi: 10.7326/0003-4819-150-9-200905050-00007.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI R01CA104721
Identifier Type: -
Identifier Source: secondary_id
16782
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.